1. Kotake Y, Iijima A, Yoshimatsu K, Tamai N, Ozawa Y, Koyanagi N, Kitoh K, Nomura H.. (1994) Synthesis and antitumor activities of novel 6-5 fused ring heterocycle antifolates: N-[4-[omega-(2-amino-4-substituted-6,7-dihydrocyclopenta [d]pyrimidin-5-yl)alkyl]benzoyl]-L-glutamic acids., 37 (11): [PMID:8201595] [10.1021/jm00037a012] |
2. Rosowsky A, Wright JE, Vaidya CM, Forsch RA, Bader H.. (2000) Analogues of the potent nonpolyglutamatable antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine (PT523) with modifications in the side chain, p-aminobenzoyl moiety, or 9,10-bridge: synthesis and in vitro antitumor activity., 43 (8): [PMID:10780919] [10.1021/jm990630f] |
3. Nair MG, Nanavati NT, Kumar P, Gaumont Y, Kisliuk RL.. (1988) Synthesis and biological evaluation of poly-gamma-glutamyl metabolites of 10-deazaaminopterin and 10-ethyl-10-deazaaminopterin., 31 (1): [PMID:2447278] [10.1021/jm00396a029] |
4. DeGraw JI, Christie PH, Kisliuk RL, Gaumont Y, Sirotnak FM.. (1990) Synthesis and antifolate properties of 9-alkyl-10-deazaminopterins., 33 (1): [PMID:2296020] [10.1021/jm00163a035] |
5. Rosowsky A, Bader H, Wright JE, Keyomarsi K, Matherly LH.. (1994) Synthesis and biological activity of N omega-hemiphthaloyl-alpha,omega- diaminoalkanoic acid analogues of aminopterin and 3',5-dichloroaminopterin., 37 (14): [PMID:8035423] [10.1021/jm00040a008] |
6. DeGraw JI, Colwell WT, Piper JR, Sirotnak FM.. (1993) Synthesis and antitumor activity of 10-propargyl-10-deazaaminopterin., 36 (15): [PMID:8340923] [10.1021/jm00067a020] |
7. Abraham A, McGuire JJ, Galivan J, Nimec Z, Kisliuk RL, Gaumont Y, Nair MG.. (1991) Folate analogues. 34. Synthesis and antitumor activity of non-polyglutamylatable inhibitors of dihydrofolate reductase., 34 (1): [PMID:1992121] [10.1021/jm00105a035] |
8. DeGraw JI, Colwell WT, Crase J, Smith RL, Piper JR, Waud WR, Sirotnak FM.. (1997) Analogues of methotrexate in rheumatoid arthritis. 1. Effects of 10-deazaaminopterin analogues on type II collagen-induced arthritis in mice., 40 (3): [PMID:9022804] [10.1021/jm9505526] |
9. Gossett LS, Habeck LL, Gates SB, Andis SL, Worzalla JF, Schultz RM, Mendelsonn LG, Kohler W, Ratnam M, Grindey GB, Shih C. (1996) Synthesis and biological evaluation of a new series of dihydrofolate reductase inhibitors based on the 4-(2,6-diamino-5-pyrimidinyl)alkyl-L-glutamic acid structure, 6 (4): [10.1016/0960-894X(96)00053-4] |
10. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF.. (2010) Thousands of chemical starting points for antimalarial lead identification., 465 (7296): [PMID:20485427] [10.1038/nature09107] |
11. Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, Nagle A, Adrián F, Matzen JT, Anderson P, Nam TG, Gray NS, Chatterjee A, Janes J, Yan SF, Trager R, Caldwell JS, Schultz PG, Zhou Y, Winzeler EA.. (2008) In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen., 105 (26): [PMID:18579783] [10.1073/pnas.0802982105] |
12. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
13. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
14. St. Jude Leishmania screening dataset., [10.6019/CHEMBL3433997] |